Wordt geladen...
Treatment of mucosa associated lymphoid tissue lymphoma with a long‐term once‐weekly regimen of oral azithromycin: Results from the phase II MALT—A trial
The macrolide clarithromycin has been reported as active for therapy of mucosa associated lymphoid tissue (MALT) lymphoma. Pharmacokinetic properties, however, require continuous daily intake over a prolonged period of time. As the macrolide azithromycin is characterized by a long half‐life as well...
Bewaard in:
| Gepubliceerd in: | Hematol Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6585850/ https://ncbi.nlm.nih.gov/pubmed/30153341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hon.2555 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|